SEC Form 4 · accession 0001457612-15-000022
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — VP of Research
Period of report
Dec 14, 2015
Accepted (ET)
Dec 15, 2015 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2015 | M | 5,462 | $2.02 | A | 7,343 | D | |
| Common Stock | Dec 14, 2015 | M | 3,444 | $2.02 | A | 10,787 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $2.02 | Dec 14, 2015 | M | 5,462 | D | — | Feb 17, 2021 | Common Stock | 5,462 | 0 | D |
| Option to purchase Common StockF1 | $2.02 | Dec 14, 2015 | M | 3,444 | D | — | Feb 17, 2021 | Common Stock | 3,444 | 0 | D |
Explanation of responses
- F1The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.